307 related articles for article (PubMed ID: 37765156)
1. Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates.
Marchesi E; Perrone D; Navacchia ML
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765156
[TBL] [Abstract][Full Text] [Related]
2. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
3. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
4. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers.
Zhang S; Yi C; Li WW; Luo Y; Wu YZ; Ling HB
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200086. PubMed ID: 35484335
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.
Wong YK; Xu C; Kalesh KA; He Y; Lin Q; Wong WSF; Shen HM; Wang J
Med Res Rev; 2017 Nov; 37(6):1492-1517. PubMed ID: 28643446
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
Ma Z; Woon CY; Liu CG; Cheng JT; You M; Sethi G; Wong AL; Ho PC; Zhang D; Ong P; Wang L; Goh BC
Front Pharmacol; 2021; 12():828856. PubMed ID: 35035355
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive overview of Artemisinin and its derivatives as anticancer agents.
Zeng ZW; Chen D; Chen L; He B; Li Y
Eur J Med Chem; 2023 Feb; 247():115000. PubMed ID: 36538859
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity of Artemisinin and its Derivatives.
Slezakova S; Ruda-Kucerova J
Anticancer Res; 2017 Nov; 37(11):5995-6003. PubMed ID: 29061778
[TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
Zhang B
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900240. PubMed ID: 31797422
[TBL] [Abstract][Full Text] [Related]
11. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Li Y; Zhou X; Liu J; Yuan X; He Q
Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
[TBL] [Abstract][Full Text] [Related]
13. Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives.
Sun X; Yan P; Zou C; Wong YK; Shu Y; Lee YM; Zhang C; Yang ND; Wang J; Zhang J
Med Res Rev; 2019 Nov; 39(6):2172-2193. PubMed ID: 30972803
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Cytotoxic Evaluation of Artemisinin-triazole Hybrids.
Tien DD; Giang LNT; Anh DTT; Dung NT; Ha TN; Ha NTT; Phuong HT; Chinh PT; Van Kiem P; Van Tuyen N
Nat Prod Commun; 2016 Dec; 11(12):1789-1792. PubMed ID: 30508334
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial and anticancer properties of artesunate and other artemisinins: current development.
Khanal P
Monatsh Chem; 2021; 152(4):387-400. PubMed ID: 33814617
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Artemisinin-Based Hybrid and Dimer Derivatives as Antimelanoma Agents.
Botta L; Filippi S; Bizzarri BM; Zippilli C; Meschini R; Pogni R; Baratto MC; Villanova L; Saladino R
ACS Omega; 2020 Jan; 5(1):243-251. PubMed ID: 31956771
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment.
Wang Y; Yuan X; Ren M; Wang Z
Am J Chin Med; 2024; 52(1):161-181. PubMed ID: 38328829
[TBL] [Abstract][Full Text] [Related]
18. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities.
Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB
Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339
[TBL] [Abstract][Full Text] [Related]
19. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
[TBL] [Abstract][Full Text] [Related]
20. An Overview of Dihydroartemisinin as a Promising Lead Compound for Development of Anticancer Agents.
Olatunde OZ; Yong J; Lu C
Mini Rev Med Chem; 2023; 23(3):265-289. PubMed ID: 35469566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
